At the upcoming Pharmaceutical Benefits Advisory Committee (PBAC) meeting in July, there will be two submissions made relating to drugs that are used to treat myeloma, namely daratumumab and carfilzom...
May 2020 23
Copyright © 2010 - 2024 Myeloma Foundation of Australia Inc . All rights reserved. Hosted by Zenhosting